Clinical evaluation of metrizamide as a myelographic agent in the dog.

Abstract

Metrizamide, a new, water-soluble contrast agent, was clinically evaluated as a myelographic agent in 17 dogs. Nine dogs were given lumbar subarachnoid injections and six were given cisternal injections. Two dogs were given cisternal and lumbar injections; in one dog, both injections were given on the same day. The dosage ranged from 0.3 to 0.57 ml/kg of… (More)

Topics

Cite this paper

@article{Stowater1979ClinicalEO, title={Clinical evaluation of metrizamide as a myelographic agent in the dog.}, author={J L Stowater and Stephen K Kneller}, journal={Journal of the American Veterinary Medical Association}, year={1979}, volume={175 2}, pages={191-5} }